Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2000, p. 1200-1202, Vol. 38, No. 3
Belarusian Research Institute for
Epidemiology and Microbiology, Minsk, Belarus,1
and Division of Infectious and Immunologic Diseases, University
of California, Davis Medical Center, Sacramento, California
958172
Received 21 September 1999/Accepted 27 November 1999
Toxigenic Clostridium difficile is the most common
etiologic agent of hospital-acquired diarrhea in developed countries.
The role of this pathogen in nosocomial diarrhea in Eastern Europe has
not been clearly established. The goal of this study was to determine
the prevalence of C. difficile in patients and the hospital environment in Belarus and to characterize these isolates as to the
presence of toxin genes and their molecular type. C. difficile was isolated from 9 of 509 (1.8%) patients analyzed
and recovered from 28 of 1,300 (2.1%) environmental sites cultured. A
multiplex PCR assay was used to analyze the pathogenicity locus (PaLoc) of all isolates, and strain identity was determined by an arbitrarily primed PCR (AP-PCR). The targeted sequences for all the genes in the
PaLoc were amplified in all C. difficile strains examined. A predominantly homogenous group of strains was found among these isolates, with five major AP-PCR groups being identified. Eighty-three percent of environmental isolates were classified into two groups, while patient isolates grouped into three AP-PCR types, two of which
were also found in the hospital environment. Although no data on the
role of C. difficile infection or epidemiology of C. difficile-associated diarrhea (CDAD) in this country exist, the
isolation of toxigenic C. difficile from the hospital
environment suggests that this pathogen may be responsible for cases of
diarrhea of undiagnosed origin and validates our effort to further
investigate the significance of CDAD in Eastern Europe.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Isolation and Molecular Characterization of
Clostridium difficile Strains from Patients and the Hospital
Environment in Belarus
*
Corresponding author. Mailing address: School of
Medicine, University of California, Davis Medical Center, 4150 V St.,
Patient Support Services Building, Suite 1100, Sacramento, CA 95817. Phone: (916) 734-7131. Fax: (916) 734-7055. E-mail:
josilva{at}ucdavis.edu.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|